Hydroxycarbamide plus aspirine bij essentiële trombocytemie zonder hoogrisicokenmerken?

Bronnen:

1. Godfrey AL, Campbell PJ, MacLean C, et al. Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features. J Clin Oncol. 2018:JCO2018788414. [Epub ahead of print]